Biocryst Pharmaceuticals Stock Forecast

Hold candidate since Nov 17, 2025

The BioCryst Pharmaceuticals stock price fell by -0.706% on the last day (Monday, 17th Nov 2025) from $7.08 to $7.03. During the last trading day the stock fluctuated 3.00% from a day low at $7.00 to a day high of $7.21. The price has been going up and down for this period, and there has been a 2.48% gain for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -460 thousand shares and in total, 3 million shares were bought and sold for approximately $22.64 million.

The stock lies the upper part of a wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $7.12 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -19.29% during the next 3 months and, with a 90% probability hold a price between $4.67 and $5.75 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

BCRX Signals & Forecast

A buy signal was issued from a pivot bottom point on Tuesday, October 14, 2025, and so far it has risen 9.50%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The BioCryst Pharmaceuticals stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $7.10 and $7.09. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for BioCryst Pharmaceuticals stock

BioCryst Pharmaceuticals finds support from accumulated volume at $6.81 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $0.210 (3.00%) between high and low. For the last week, the stock has had daily average volatility of 3.62%.

Our recommended stop-loss: $6.65 (-5.34%) (This stock has low daily movements and this gives low risk. There is a buy signal from a pivot bottom found 24 days ago.)

Trading Expectations (BCRX) For The Upcoming Trading Day Of Tuesday 18th

For the upcoming trading day on Tuesday, 18th we expect BioCryst Pharmaceuticals to open at $7.08, and during the day (based on 14 day Average True Range), to move between $6.89 and $7.17, which gives a possible trading interval of +/-$0.280 (+/-4.06%) up or down from last closing price. If BioCryst Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 4.06% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $7.08 (0.71%) than the support at $6.81 (3.13%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is BioCryst Pharmaceuticals stock A Buy?

BioCryst Pharmaceuticals holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.

Current score: -0.110 Hold/Accumulate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on November 18, 2025 - $7.08 ( 0.711%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk